The role of inflammation in the development of epilepsy

A Rana, AE Musto - Journal of neuroinflammation, 2018 - Springer
Epilepsy, a neurological disease characterized by recurrent seizures, is often associated
with a history of previous lesions in the nervous system. Impaired regulation of the activation …

Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury

H Khan, K Sharma, A Kumar, A Kaur, TG Singh - Inflammation Research, 2022 - Springer
Introduction Ischemia–reperfusion injury (IRI) is the inexplicable aggravation of cellular
dysfunction that results in blood flow restoration to previously ischemic tissues. COX …

Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins

S Rangaraju, EB Dammer, SA Raza, T Gao… - Molecular …, 2018 - Springer
Background Microglia are innate immune cells of the brain that perform phagocytic and
inflammatory functions in disease conditions. Transcriptomic studies of acutely-isolated …

Differential effect of an evolving amyloid and tau pathology on brain phospholipids and bioactive lipid mediators in rat models of Alzheimer-like pathology

S Do Carmo, MAI Kautzmann, S Bhattacharjee… - Journal of …, 2024 - Springer
Background Brain inflammation contributes significantly to the pathophysiology of
Alzheimer's disease, and it is manifested by glial cell activation, increased production of …

Sleep disturbance and Alzheimer's disease: the glial connection

A Sunkaria, S Bhardwaj - Neurochemical Research, 2022 - Springer
Poor quality and quantity of sleep are very common in elderly people throughout the world.
Growing evidence has suggested that sleep disturbances could accelerate the process of …

Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy

CR Reschke, LFA Silva, VR Vangoor, M Rosso… - Molecular Therapy, 2021 - cell.com
Oligonucleotide therapies offer precision treatments for a variety of neurological diseases,
including epilepsy, but their deployment is hampered by the blood-brain barrier (BBB) …

An update of cyclooxygenase (COX)-inhibitors in epilepsy disorders

A Dhir - Expert Opinion on Investigational Drugs, 2019 - Taylor & Francis
Introduction: Neuroinflammation has a critical role in brain disorders. Cyclooxygenase
(COX) is one of the principal drug targets for the reduction of neuroinflammation; however …

A peripheral lipid sensor GPR120 remotely contributes to suppression of PGD2-microglia-provoked neuroinflammation and neurodegeneration in the mouse …

K Iwasa, S Yamamoto, K Yamashina… - Journal of …, 2021 - Springer
Background Neuroinflammation is a key pathological component of neurodegenerative
disease and is characterized by microglial activation and the secretion of proinflammatory …

Peptide-mediated targeted delivery of SOX9 nanoparticles into astrocytes ameliorates ischemic brain injury

HJ Shin, SG Choi, F Qu, MH Yi, CH Lee, SR Kim… - Nanoscale, 2024 - pubs.rsc.org
Astrocytes are highly activated following brain injuries, and their activation influences
neuronal survival. Additionally, SOX9 expression is known to increase in reactive astrocytes …

[HTML][HTML] Ursolic acid treatment suppresses cuprizone-induced demyelination and motor dysfunction via upregulation of IGF-1

S Yamamoto, C Sakemoto, K Iwasa… - Journal of …, 2020 - Elsevier
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system,
characterized by apoptotic death of mature oligodendrocytes, neuroinflammation, and motor …